#PFIZER OPERATION WARP SPEED HOW TO#

15, 2020, only four days after FDA approval of the Pfizer vaccine.Д¬onsistent with OWSвЂ™s stated goal, some 50 million initial doses of approved COVID-19 vaccine were available on Jan. The first Americans were vaccinated on Dec. 11, 2020, the Food and Drug Administration (FDA) approved for emergency use authorization (EUA) a vaccine produced by Pfizer for вЂњthe prevention of coronavirus disease 2019 (COVID-19) in individuals 16 years of age and older.вЂќ Approval of ModernaвЂ™s vaccine followed seven days later. Some ten months later, the results of OWS are as follows: (Currently, 251 vaccines are in the process of development).

The pursuit of multiple vaccine types built redundancy into the program to insure as many approved vaccine types as possible. OWS called for clinical trials, manufacturing, and logistics to be conducted on a parallel rather than a sequential basis. The most innovative feature of OWS was government purchases of large quantities of vaccine types undergoing clinical trials, irrespective of the outcome (such as $2 billion and $483 million in early purchases from Pfizer and Moderna, respectively). OWS was constituted as a projected $18 billion business-government-military partnership, charged to вЂњproduce and deliver 300 million doses of safe and effective vaccines with the initial doses available by January 2021, as part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.вЂќ No date was set for fulfilling the 300 million doses target, other than the understanding that it would be вЂњacceleratedвЂќ relative to conventional standards. Additionally, the nearly 2 billion dollars awarded to Pfizer will go a long way in the manufacturing and distribution of the Pfizer vaccine in development.Former President Donald Trump formally announced Operation Warp Speed (OWS) on May 15, 2020. But it also appears to undermine the claim that Pfizer is operating entirely outside Operation Warp Speed.ДЄ senior administration official told Yahoo News that since вЂњthe early days of March when President Trump convened pharmaceutical companies at the White House, Pfizer has been a part of the incredible public-private partnership forged to combat the coronavirus pandemic. Technically, that agreement has nothing to do with the development of the vaccine. While other pharmaceutical companies did take federal funds to develop a vaccine, Pfizer declined to do so, the only one of the major prospective developers to go it alone.ДЄt the same time, on July 22, Pfizer agreed to a $1.95 billion deal with the Trump administration вЂњfor large-scale production and nationwide delivery of 100 million doses of a COVID-19 vaccine in the United States following the vaccineвЂ™s successful manufacture and approval.вЂќ Operation Warp Speed was started in the spring as вЂњa public-private partnership to facilitate, at an unprecedented pace, the development, manufacturing, and distribution of COVID-19 countermeasures,вЂќ according to the Trump administrationвЂ™s own description of the program. Still, the issue is somewhat more complicated than what social media may lead one to believe. President-elect Joe Biden meets with members of the Transition COVID-19 Advisory Board in Wilmington, Del., on Monday. Trump will want to claim credit for any successes in the coming months, while his detractors will point to forces - private industry, in the Pfizer case - beyond his influence.

Vaccines and therapeutics could radically change the course of the pandemic, but they have to be developed, manufactured and distributed. President-elect Biden, meanwhile, is moving ahead with a transition.ДЄll this is happening as coronavirus cases mount across the land. Trump has still refused to concede the presidential election.

#PFIZER OPERATION WARP SPEED HOW TO#

The row over Warp Speed is part of what will be a near-certain dispute between the Trump and Joe Biden camps over how to handle the pandemic. The assertion infuriated supporters of the president, who had been promising a vaccine for months, and was also challenged by some who pointed out that the company is on track to receive almost $2 billion from the administration for production. government, or from anyone,вЂќ Kathrin Jansen, the companyвЂ™s vice president for vaccine research, told the Times. We have never taken any money from the U.S. (John Nacion/SOPA Images/LightRocket via Getty Images)

Pfizer operation warp speed